Cargando…

Rheumatoid Arthritis Co-relation with Anti-CCP Antibodies with special reference to its Prevalence in Asymptomatic First-Degree Relatives

OBJECTIVES: Rheumatoid Arthritis (RA) is a chronic inflammatory autoimmune disease. First-degree relatives (FDR) of patients with RA sharing genetic and environmental risk factors for RA may represent a pre-RA state. This study showed the clinical co-relation of RA with Anti-Cyclic citrullinated pep...

Descripción completa

Detalles Bibliográficos
Autores principales:	GR, Pramod, Dihingia, Prasanta, Jha, Anshu Kumar, Gadgade, Akash, Agarwal, Deepti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092096/ https://www.ncbi.nlm.nih.gov/pubmed/35611105 http://dx.doi.org/10.31138/mjr.33.1.42

Ejemplares similares

Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis
por: Mekic, Mevludin, et al.
Publicado: (2020)

The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
por: Serdaroğlu, Münevver, et al.
Publicado: (2008)

Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis
por: Whittingham, Senga F., et al.
Publicado: (2017)

Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays
por: Poulsen, Thomas B. G., et al.
Publicado: (2021)

Adjusting for sex and anti-CCP levels in linkage analysis of rheumatoid arthritis
por: Lebrec, Jérémie JP, et al.
Publicado: (2007)

The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases
por: Chou, CT, et al.
Publicado: (2007)

Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospital
por: Jha, Anshu Kumar, et al.
Publicado: (2015)

Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
por: Harrold, Leslie R., et al.
Publicado: (2023)

Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays
por: Vos, Ine, et al.
Publicado: (2017)

Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis
por: Ediz, Levent, et al.
Publicado: (2011)

Correlation between high-frequency ultrasonography of patients with early rheumatoid arthritis and anti-CCP antibody
por: Yang, Jie, et al.
Publicado: (2019)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody
por: Kamiya, Hiroyuki, et al.
Publicado: (2021)

Predictors of interest in predictive testing for rheumatoid arthritis among first degree relatives of rheumatoid arthritis patients
por: Wells, Imogen, et al.
Publicado: (2021)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

Predictors of perceived risk in first-degree relatives of patients with rheumatoid arthritis
por: Bunnewell, Sarah, et al.
Publicado: (2022)

Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
por: van Venrooij, Walther J., et al.
Publicado: (2007)

The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis
por: Karimifar, Mansoor, et al.
Publicado: (2012)

Osteoprotegerin CGA Haplotype Protection against Cerebrovascular Complications in Anti-CCP Negative Patients with Rheumatoid Arthritis
por: Genre, Fernanda, et al.
Publicado: (2014)

The TNFA -857C/T Polymorphism: Association with Rheumatoid Arthritis and Anti-CCP Levels in a Mexican Population
por: Agraz-Cibrián, Juan Manuel, et al.
Publicado: (2019)

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
por: Fujita, Yuya, et al.
Publicado: (2020)

CCP5 and CCP6 retain CP110 and negatively regulate ciliogenesis
por: Wang, Yujuan, et al.
Publicado: (2023)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity
por: Arroyo-Villa, Irene, et al.
Publicado: (2012)

Asymptomatic Atherosclerosis in Egyptian Rheumatoid Arthritis Patients and Its Relation to Disease Activity
por: Elshereef, Rawhya R., et al.
Publicado: (2015)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Periodontitis in First Degree-Relatives of Individuals With Rheumatoid Arthritis: A Short Narrative Review
por: Zekeridou, Alkisti, et al.
Publicado: (2022)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates
por: Zintzaras, Elias, et al.
Publicado: (2012)

A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis
por: Son, James J., et al.
Publicado: (2021)

The influence of the -94 Ins/Del ATTG polymorphism of NFkB on the anti-CCP antibody levels in patients with rheumatoid arthritis
por: Ayón-Pérez, Miriam Fabiola, et al.
Publicado: (2021)

Ligand fitting with CCP4
por: Nicholls, Robert A.
Publicado: (2017)

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Predicted models and CCP4
por: Simpkin, Adam J., et al.
Publicado: (2023)

The cytosolic carboxypeptidases CCP2 and CCP3 catalyze posttranslational removal of acidic amino acids
por: Tort, Olivia, et al.
Publicado: (2014)

CCP4i2: the new graphical user interface to the CCP4 program suite
por: Potterton, Liz, et al.
Publicado: (2018)

Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
por: Lampert, Erika J., et al.
Publicado: (2013)

PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking
por: Massarenti, Laura, et al.
Publicado: (2021)

Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sijo0q8ka4baptu283ee3cotbk